Comments

Tenaya Therapeutics

TNYANASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$3.39
00.00%
At close: Jul 19, 4:02 PM EDT
$3.39
00.00%
After Hours: Jul 19, 4:02 PM EDT
15 minutes delayed
Tenaya Therapeutics (TNYA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$7.00
Consensus Price Target1
$19.17

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Tenaya Therapeutics (NASDAQ:TNYA) Stock, Analyst Ratings, Price Targets, Forecasts

Tenaya Therapeutics Inc has a consensus price target of $19.17 based on the ratings of 8 analysts. The high is $40 issued by Piper Sandler on August 24, 2021. The low is $7 issued by Leerink Partners on November 30, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co. on July 8, 2024, May 16, 2024, and May 15, 2024, respectively. With an average price target of $17.33 between HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co., there's an implied 411.31% upside for Tenaya Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
1
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Chardan Capital
Leerink Partners
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Tenaya Therapeutics

Buy NowGet Alert
07/08/2024Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
$18 → $18ReiteratesBuy → BuyGet Alert
06/10/2024Buy Now—William Blair
Sami Corwin
—Initiates → OutperformGet Alert
05/16/2024Buy Now371.98%Canaccord Genuity
Whitney Ijem
$18 → $16MaintainsBuyGet Alert
05/15/2024Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
 → $18ReiteratesBuy → BuyGet Alert
03/21/2024Buy Now489.97%Chardan Capital
Geulah Livshits
 → $20ReiteratesBuy → BuyGet Alert
03/20/2024Buy Now430.97%Canaccord Genuity
Whitney Ijem
$19 → $18MaintainsBuyGet Alert
03/19/2024Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
 → $18ReiteratesBuy → BuyGet Alert
11/30/2023Buy Now106.49%Leerink Partners
Mani Foroohar
 → $7Initiates → OutperformGet Alert
10/09/2023Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
 → $18ReiteratesBuy → BuyGet Alert
08/14/2023Buy Now578.47%Chardan Capital
Geulah Livshits
 → $23ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now401.47%Canaccord Genuity
Whitney Ijem
$18 → $17MaintainsBuyGet Alert
08/10/2023Buy Now312.98%Morgan Stanley
Matthew Harrison
$13 → $14MaintainsOverweightGet Alert
08/10/2023Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
 → $18ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now578.47%Chardan Capital
Geulah Livshits
$24 → $23MaintainsBuyGet Alert
05/11/2023Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
 → $18ReiteratesBuy → BuyGet Alert
03/09/2023Buy Now607.96%Chardan Capital
Geulah Livshits
$28 → $24MaintainsBuyGet Alert
03/09/2023Buy Now430.97%HC Wainwright & Co.
Joseph Pantginis
$25 → $18MaintainsBuyGet Alert
01/24/2023Buy Now283.48%Morgan Stanley
Matthew Harrison
$15 → $13MaintainsOverweightGet Alert
11/11/2022Buy Now725.96%Chardan Capital
Geulah Livshits
$30 → $28MaintainsBuyGet Alert
11/08/2022Buy Now519.47%Canaccord Genuity
Whitney Ijem
 → $21Initiates → BuyGet Alert
08/11/2022Buy Now784.96%Chardan Capital
Geulah Livshits
$31 → $30MaintainsBuyGet Alert
06/15/2022Buy Now637.46%HC Wainwright & Co.
Joseph Pantginis
 → $25Initiates → BuyGet Alert
05/17/2022Buy Now342.48%Morgan Stanley
Matthew Harrison
$19 → $15MaintainsOverweightGet Alert
08/24/2021Buy Now—Cowen & Co.——Initiates → OutperformGet Alert
08/24/2021Buy Now814.45%Morgan Stanley
Matthew Harrison
—Initiates → OverweightGet Alert
08/24/2021Buy Now991.45%Chardan Capital
Geulah Livshits
—Initiates → BuyGet Alert
08/24/2021Buy Now1079.94%Piper Sandler
Yasmeen Rahimi
—Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Tenaya Therapeutics (TNYA) stock?

A

The latest price target for Tenaya Therapeutics (NASDAQ:TNYA) was reported by HC Wainwright & Co. on July 8, 2024. The analyst firm set a price target for $18.00 expecting TNYA to rise to within 12 months (a possible 430.97% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Tenaya Therapeutics (TNYA)?

A

The latest analyst rating for Tenaya Therapeutics (NASDAQ:TNYA) was provided by HC Wainwright & Co., and Tenaya Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Tenaya Therapeutics (TNYA)?

A

There is no last upgrade for Tenaya Therapeutics

Q

When was the last downgrade for Tenaya Therapeutics (TNYA)?

A

There is no last downgrade for Tenaya Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Tenaya Therapeutics (TNYA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on July 8, 2024 so you should expect the next rating to be made available sometime around July 8, 2025.

Q

Is the Analyst Rating Tenaya Therapeutics (TNYA) correct?

A

While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a reiterated with a price target of $18.00 to $18.00. The current price Tenaya Therapeutics (TNYA) is trading at is $3.39, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch